Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 241 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Breast Neoplasms 161434 Metabolism of pregnenolone by human breast cancer. Evidence for 17 alpha-hydroxylase and 17,20-lyase. ongoing research
therapeutic application
unassigned
1
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Neoplasms 161434 Metabolism of pregnenolone by human breast cancer. Evidence for 17 alpha-hydroxylase and 17,20-lyase. ongoing research
therapeutic application
unassigned
1
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Disorder of Sex Development, 46,XY 1003059 Production of male pseudohermaphroditism in rats by two new inhibitors of steroid 17alpha-hydroxylase and C 17-20 lyase. therapeutic application
unassigned
3
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Herpes Zoster 1319681 Studies of adrenal steroidogenic enzymes in guinea pigs. ongoing research
unassigned
2
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19steroid 17alpha-monooxygenase deficiency 1515452 Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg(496)----Cys, Gln(461)----Stop) actually cause combined 17 alpha-hydroxylase/17,20-lyase deficiency. causal interaction
therapeutic application
unassigned
4
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Prostatic Neoplasms 1606043 4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase. therapeutic application
unassigned
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Pituitary ACTH Hypersecretion 1655322 Ketoconazole and plasma and urine steroid levels in Cushing's disease. therapeutic application
unassigned
1
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19steroid 17alpha-monooxygenase deficiency 2166072 A case of male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency and hormonal profiles in the nuclear family. causal interaction
diagnostic usage
unassigned
3
3
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19steroid 17alpha-monooxygenase deficiency 2843762 Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency. causal interaction
unassigned
3
0
Show all pathways known for 1.14.14.19Display the word mapDisplay the reaction diagram Show all sequences 1.14.14.19Pituitary ACTH Hypersecretion 3023421 Use of ketoconazole in the treatment of Cushing's syndrome. causal interaction
therapeutic application
unassigned
1
1
0
Results 1 - 10 of 241 > >>